CLINICAL_TRIALS
withdrawal
· 2022-11-18
Clinical Trial Update: Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI in Adenomyosis [Phase 3]
Summary
A Phase 3 trial evaluating ultra-long versus long down-regulation protocols in IVF/ICSI for adenomyosis has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Hospital, Toulouse | Conditions: Adenomyosis | Phase 3 | Status: WITHDRAWN